SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-017348
Filing Date
2022-03-08
Accepted
2022-03-08 20:03:40
Documents
1
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6272
  Complete submission text file 0001209191-22-017348.txt   7905
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 MARGALITA DRIVE SAN RAFAEL CA 94901
Business Address
Barry Richard (Reporting) CIK: 0001562371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 22723507